Previous Close | 3.2000 |
Open | 3.2000 |
Bid | 0.1500 |
Ask | 3.0000 |
Strike | 35.00 |
Expire Date | 2024-07-19 |
Day's Range | 2.4000 - 3.5000 |
Contract Range | N/A |
Volume | |
Open Interest | 31 |
Key Insights Protagonist Therapeutics to hold its Annual General Meeting on 20th of June Salary of US$655.2k is part of...
Long term follow-up from REVIVE Phase 2 study up to 3 years shows durable hematocrit (Hct) control (< 45%), decreased phlebotomy use, long-term tolerability, and no new safety signals in patients with polycythemia vera Patients receiving rusfertide ...
Protagonist Therapeutics (NASDAQ:PTGX) has had a great run on the share market with its stock up by a significant 24...